Naratriptan
Back to searchMolecule Structure
Scientific Name
Naratriptan
Description of the Drug
Naratriptan is a 5-HT1B/1D receptor agonist used to treat migraines.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00952
http://www.drugbank.ca/drugs/DB00952
Brand Name(s)
Amerge, Naratriptan
Company Owner(s)
Apotex Corp, Padagis Us Llc, Sun Pharmaceutical Industries Ltd, Chartwell Rx Sciences Llc, Ani Pharmaceuticals Inc, Orbion Pharmaceuticals Private Ltd, Mylan Pharmaceuticals Inc, Glaxosmithkline Llc, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 1b (5-HT1b) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1898 |
Serotonin 1d (5-HT1d) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1983 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL68753 | ||
PharmGKB | PA450597 | ||
Human Metabolome Database | HMDB0015087 | ||
DrugBank | DB00952 | ||
PubChem: Thomson Pharma | 14802133 | ||
PubChem | 4440 | ||
NMRShiftDB | 10021715 | ||
Nikkaji | J550.688C | ||
BindingDB | 50073682 | ||
EPA CompTox Dashboard | DTXSID7023354 | ||
DrugCentral | 1884 | ||
ChemicalBook | CB1874790 | ||
Guide to Pharmacology | 45 | ||
rxnorm | NARATRIPTAN HYDROCHLORIDE | AMERGE | NARATRIPTAN |
KEGG Ligand | C07792 | ||
ChEBI | 7478 | ||
ZINC | ZINC000000004076 |